Rainer Kunstfeld Selected Research

Heterologous Transplantation (Xenotransplantation)

5/2009

Erlotinib and bevacizumab have synergistic activity against melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rainer Kunstfeld Research Topics

Disease

16	Neoplasms (Cancer) 01/2016 - 03/2003
10	Melanoma (Melanoma, Malignant) 01/2019 - 03/2003
6	Neoplasm Metastasis (Metastasis) 03/2015 - 04/2005
4	Basal Cell Carcinoma (Rodent Ulcer) 12/2018 - 06/2015
2	Inflammation (Inflammations) 02/2015 - 08/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2015 - 12/2003
2	Carcinogenesis 05/2014 - 04/2005
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2006 - 08/2004
1	Granuloma Annulare 01/2018
1	Spasm (Spasms) 01/2017
1	Skin Neoplasms (Skin Cancer) 02/2015
1	Merkel Cell Carcinoma 01/2013
1	Contact Dermatitis (Eczema, Contact) 01/2011
1	Nevus (Nevi) 01/2011
1	Multiple Myeloma 05/2009
1	Skin Diseases (Skin Disease) 12/2006
1	Lymphatic Metastasis 04/2005
1	Hyperplasia 08/2004
1	Hypersensitivity (Allergy) 08/2004
1	Rheumatoid Arthritis 08/2004
1	Wounds and Injuries (Trauma) 07/2004
1	Fever (Fevers) 01/2004
1	Exanthema (Rash) 01/2004
1	Drug Hypersensitivity Syndrome 01/2004
1	Vulvar Lichen Sclerosus 07/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2006
5	ProteomeIBA 01/2019 - 05/2009
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2009 - 12/2003
4	HhAntag691IBA 12/2018 - 06/2015
4	Pharmaceutical PreparationsIBA 06/2015 - 03/2003
2	Monoclonal AntibodiesIBA 08/2012 - 05/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2004 - 07/2004
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2017
1	sonidegibIBA 10/2016
1	VemurafenibIBA 03/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2015
1	Extracellular Matrix ProteinsIBA 03/2015
1	ResveratrolIBA 03/2015
1	Angiogenesis InhibitorsIBA 05/2014
1	DesminIBA 05/2014
1	ElementsIBA 03/2014
1	Cisplatin (Platino)FDA LinkGeneric 07/2013
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 08/2012
1	VimentinIBA 08/2012
1	IpilimumabIBA 08/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2012
1	Therapeutic UsesIBA 01/2012
1	ciglitazoneIBA 01/2012
1	Troglitazone (Rezulin)FDA Link 01/2012
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2012
1	LigandsIBA 01/2012
1	15-deoxyprostaglandin J2IBA 01/2012
1	PaxillinIBA 01/2012
1	Irritants (Vesicants)IBA 01/2011
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 08/2010
1	TenascinIBA 08/2010
1	Endothelin-1 (Endothelin 1)IBA 08/2010
1	Indicators and Reagents (Reagents)IBA 08/2010
1	3,3',4,4',5,5'-hexahydroxystilbeneIBA 06/2010
1	StilbenesIBA 06/2010
1	Bevacizumab (Avastin)FDA Link 05/2009
1	matrigelIBA 05/2009
1	ErbB Receptors (EGF Receptor)IBA 05/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2009
1	CarcinogensIBA 05/2009
1	PeriostinIBA 05/2009
1	Biomarkers (Surrogate Marker)IBA 05/2009
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2006
1	Messenger RNA (mRNA)IBA 12/2006
1	Dimethyl FumarateIBA 12/2006
1	Green Fluorescent ProteinsIBA 04/2005
1	Blocking AntibodiesIBA 08/2004
1	Biological ProductsIBA 08/2004
1	IntegrinsIBA 07/2004
1	monocrystalline iron oxide nanoparticle (MION)IBA 07/2004
1	Surface Antigens (Surface Antigen)IBA 07/2004
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2004
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2003
1	Liposomes (Liposome)IBA 03/2003
1	cremophor ELIBA 03/2003

Therapy/Procedure

3	Therapeutics 01/2018 - 08/2010
1	Extracorporeal Shockwave Therapy 01/2018
1	Immunotherapy 01/2016
1	Drug Therapy (Chemotherapy) 01/2013
1	Heterologous Transplantation (Xenotransplantation) 05/2009
1	Intraperitoneal Injections 12/2003